Randomized multicenter phase 2 study of pomalidomide, cyclophosphamide, and dexamethasone in relapsed refractory myeloma

Autor: Baz, Rachid C. *, Martin, Thomas G., III, Lin, Hui-Yi, Zhao, Xiuhua, Shain, Kenneth H., Cho, Hearn J., Wolf, Jeffrey L., Mahindra, Anuj, Chari, Ajai, Sullivan, Daniel M., Nardelli, Lisa A., Lau, Kenneth, Alsina, Melissa, Jagannath, Sundar
Zdroj: In Blood 26 May 2016 127(21):2561-2568
Databáze: ScienceDirect